Personal genomics: New drugs target common cancers

lungs
Tens of thousands of Americans with tumors from certain types of lung cancer have mutations that might be treated by new drugs that are already in the pipeline or that could be easily developed–a dramatic demonstration of the promise of personalized genomic-based medicine.
Additional Resources:
{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}
skin microbiome x final

Infographic: Could gut bacteria help us diagnose and treat diseases? This is on the horizon thanks to CRISPR gene editing

Humans are never alone. Even in a room devoid of other people, they are always in the company of billions ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.